Structure-based Lead Identification
Structure-Based Lead Identification is a computational drug discovery approach that identifies potential lead compounds by leveraging the three-dimensional structure of a biological target to guide the search for molecules capable of specifically interacting with functionally relevant sites.
196
Publications
10.6K
Citations
1.7K
Authors
424
Institutions
Publications per year
2017–2026
74
196
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai, Bing Zhang, Xia-Ming Jiang et al. · Science · 2020 · 1.6K citations · Full text
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
E. Wahlberg, T. Karlberg, E. Kouznetsova et al. · Nature Biotechnology · 2012 · 460 citations
Andrew Woodhead, Hayley C. Angove, Maria G. Carr et al. · Journal of Medicinal Chemistry · 2010 · 263 citations
1–5 of 196
1.7K
3
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 1.7K
424

Chinese Academy of Sciences
Beijing, China
9 h-index
74 publications
25.7K citations
Shanghai Institute of Materia Medica
Pudong, China
5 h-index
44 publications
20.2K citations
University of Chinese Academy of Sciences
Beijing, China
5 h-index
24 publications
13.6K citations
Xiamen University
Xiamen, China
4 h-index
22 publications
478 citations
Central China Normal University
Wuhan, China
3 h-index
30 publications
642 citations

University of Basel
Basel, Switzerland
3 h-index
22 publications
702 citations

King Saud University
Riyadh, Saudi Arabia
3 h-index
5 publications
141 citations
Johnson & Johnson (United States)
New Brunswick, United States
3 h-index
22 publications
798 citations
1–8 of 424
39 publications · 2.9K citations
32
h-index
17 publications · 517 citations
15
h-index
13 publications · 465 citations
13
h-index
13 publications · 430 citations
13
h-index
JCIM · 5 publications · 165 citations
5
h-index
1–5